1. Pharmacology of cancer chemotherapy drugs for hyperthermic intraperitoneal peroperative chemotherapy in epithelial ovarian cancer
   Kurt Van der Speeten, 2013, WJOG CrossRef
2. Cyclopamine tartrate, a modulator of hedgehog signaling and mitochondrial respiration, effectively arrests lung tumor growth and progression
   Sarada Preeta Kalainayakan et al, 2019, Sci Rep CrossRef
3. Smac peptide potentiates TRAIL- or paclitaxel-mediated ovarian cancer cell death in vitro and in vivo
   HONG LUAN MAO et al, 2013 CrossRef
4. Evaluation of Potentially Predictive Markers for Anti-Angiogenic Therapy with Sunitinib in Recurrent Ovarian Cancer Patients
   Dirk O Bauerschlag et al, 2013, Translational Oncology CrossRef
5. Nachsorgeuntersuchung beim Mammakarzinom
   S. Buchholz et al, 2014, Gynäkologe CrossRef
6. Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients
   Katherine C. Fuh et al, 2015, Gynecologic Oncology CrossRef
7. Numerical simulation of vascular tumour growth under antiangiogenic treatment: addressing the paradigm of single-agent bevacizumab therapy with the use of experimental data
   Katerina D. Argyri et al, 2016, Biol Direct CrossRef
8. Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab
   Andreas Seeber et al, 2015, Oncotarget CrossRef
9. Standard Radio-Iodine Labeling Protocols Impaired the Functional Integrity of Mesenchymal Stem/Stromal Cell Exosomes
   Chang-Tong Yang et al, 2024, IJMS CrossRef